Investment Research - Asia Consumer Sector, Investory

Devi Subhakesan

Investment Research - Asia Consumer Sector. 

Equity Research experience of over 20 years. Earlier, Analyst for leading Buy and Sell-side institutions, covering markets in ASEAN, India, and North Asia. Expertise spans various sectors - Consumer Discretionary, Media, Textiles, Oil, Gas, and Coal.
Passionate about mindfulness and meditation.

Investment Research - Asia Consumer Sector

Lion Corp (4912 JP): Clean Care for Consumers, Safe Play for Investors

ASIA CONSUMER: INSIGHTS AND INVESTMENT IDEAS

Investory

Investory is a Singapore-based boutique independent equity research firm founded in January 2017 with a primary focus on consumption themes across Asia-Pacific.

We aim to generate investible ideas based on consumption trends and outlook. We screen our ideas on several parameters - product potential, long-term growth and management commitment being the most critical.  We follow a fundamental analysis approach in our stock selection process and are not restricted by market cap.

We aspire to grow into a leading source of unbiased research, free of conflict of interest, for investors yearning for independent and disciplined analysis. 

We also undertake bespoke research mandates to support our Institutional clients’ investment needs.

Our team comprises of professionals with extensive experience in the Asian equity markets, in areas ranging from research, servicing institutional clients and investment management.

Equity Bottom-Up

<a href="https://www.smartkarma.com/entities/unicharm-corp" target="_blank" data-smartkarma-citation="entities:6246:1" rel="noopener">Unicharm Corp (8113 JP)</a> is Japan's leading mask manufacturer and a dominant player across Asia in the personal hygiene care - baby/adult diapers, sanitary napkins - segment. Expect demand for its portfolio of essential personal care products to be relatively unaffected by COVID-led lifestyle changes. The impact of supply disruptions, if any, in various markets and the consequent effect on near term revenues is unclear. Expect Management to clarify on the same as it announces 1Q2020 results on May 14th. COVID-led restrictions and lifestyle changes have impacted demand for several personal care products that became optional/discretionary as consumers are restricted to their homes. But, given the essential nature of <a href="https://www.smartkarma.com/entities/unicharm-corp" target="_blank" data-smartkarma-citation="entities:6246:1" rel="noopener">Unicharm Corp (8113 JP)</a> 's products, expect its near term revenue growth to be stable.  It is well-positioned from a longer-term growth perspective as well, thanks to its balanced product portfolio targeting consumers at both ends of the demographic profile. <a href="https://www.smartkarma.com/entities/unicharm-corp" target="_blank" data-smartkarma-citation="entities:6246:1" rel="noopener">Unicharm Corp (8113 JP) </a>has delivered steady growth in revenues over the years by expanding its presence to emerging Asia, thus offsetting the declining demand in maturing markets - Japan and China.In the detailed report below we discuss  <a href="https://www.smartkarma.com/entities/unicharm-corp" target="_blank" data-smartkarma-citation="entities:6246:1" rel="noopener">Unicharm Corp (8113 JP)</a> 's investment case by (1) analyzing its product portfolio and growth prospects (2) Valuation comparison with its peer group (3) looking at its financials, consensus estimates, and management guidance.

Unicharm Corp (8113 JP) is Japan's leading mask manufacturer and a dominant player across Asia in the personal hygiene care - baby/adult diapers, sanitary napkins - segment. Expect demand for its portfolio of essential personal care products to be relatively unaffected by COVID-led lifestyle changes. The impact of supply disruptions, if any, in various markets and the consequent effect on near term revenues is unclear. Expect Management to clarify on the same as it announces 1Q2020 results on May 14th. COVID-led restrictions and lifestyle changes have impacted demand for several personal care products that became optional/discretionary as consumers are restricted to their homes. But, given the essential nature of Unicharm Corp (8113 JP) 's products, expect its near term revenue growth to be stable.  It is well-positioned from a longer-term growth perspective as well, thanks to its balanced product portfolio targeting consumers at both ends of the demographic profile. Unicharm Corp (8113 JP) has delivered steady growth in revenues over the years by expanding its presence to emerging Asia, thus offsetting the declining demand in maturing markets - Japan and China.In the detailed report below we discuss  Unicharm Corp (8113 JP) 's investment case by (1) analyzing its product portfolio and growth prospects (2) Valuation comparison with its peer group (3) looking at its financials, consensus estimates, and management guidance. 

Unicharm Corp (8113 JP): Un'mask'ing a COVID-Proof Consumer Growth Story.